A detailed history of Janus Henderson Group PLC transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 56,000 shares of OLMA stock, worth $712,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,000
Previous 1,221,662 95.42%
Holding current value
$712,320
Previous $13.8 Million 95.63%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$8.73 - $13.99 $10.2 Million - $16.3 Million
-1,165,662 Reduced 95.42%
56,000 $605,000
Q1 2024

May 15, 2024

BUY
$10.95 - $16.62 $5.71 Million - $8.67 Million
521,562 Added 74.5%
1,221,662 $13.8 Million
Q4 2023

Feb 14, 2024

BUY
$10.53 - $17.14 $7.37 Million - $12 Million
700,100 New
700,100 $9.82 Million
Q1 2023

May 15, 2023

SELL
$2.55 - $4.97 $2.48 Million - $4.83 Million
-972,127 Reduced 31.8%
2,085,179 $7.24 Million
Q4 2022

Feb 14, 2023

SELL
$2.27 - $3.76 $770,394 - $1.28 Million
-339,381 Reduced 9.99%
3,057,306 $7.49 Million
Q3 2022

Nov 14, 2022

BUY
$2.72 - $5.88 $205,506 - $444,257
75,554 Added 2.27%
3,396,687 $9.37 Million
Q2 2022

Aug 15, 2022

SELL
$2.04 - $4.61 $482,054 - $1.09 Million
-236,301 Reduced 6.64%
3,321,133 $13.5 Million
Q1 2022

May 16, 2022

BUY
$3.89 - $9.43 $2.19 Million - $5.3 Million
561,994 Added 18.76%
3,557,434 $15.1 Million
Q4 2021

Feb 14, 2022

BUY
$8.75 - $30.71 $4.55 Million - $16 Million
519,610 Added 20.99%
2,995,440 $28 Million
Q3 2021

Nov 16, 2021

SELL
$22.96 - $30.13 $17.2 Million - $22.6 Million
-748,848 Reduced 23.22%
2,475,830 $68.2 Million
Q2 2021

Aug 16, 2021

SELL
$21.15 - $36.14 $7.42 Million - $12.7 Million
-350,890 Reduced 9.81%
3,224,678 $90.3 Million
Q1 2021

May 17, 2021

SELL
$27.81 - $53.64 $1.76 Million - $3.39 Million
-63,270 Reduced 1.74%
3,575,568 $114 Million
Q4 2020

Feb 16, 2021

BUY
$37.09 - $54.5 $135 Million - $198 Million
3,638,838 New
3,638,838 $161 Million

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $514M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.